Suppr超能文献

镓- DOTATATE PET/CT:在疑似胰岛素瘤的病例的成像中,它的可靠性如何?

Ga-DOTATATE PET/CT: How is it reliable in imaging of cases having clinical suspicion of insulinomas?

机构信息

Department of Radiology, Helwan University, Cairo, Egypt.

Department of Radiology, Ain Shams University, Cairo, Egypt.

出版信息

Eur J Radiol. 2024 Oct;179:111669. doi: 10.1016/j.ejrad.2024.111669. Epub 2024 Aug 8.

Abstract

PURPOSE

This retrospective study evaluates the value of Ga-DOTATATE PET/CT in the diagnosis and localization of insulinomas, whether sporadic, malignant or MEN-1 associated insulinoma.

METHOD

The study included 43 patients, having clinical (symptomatic hypoglycemia) and/or laboratory suspicion of having insulinoma (72 h fasting test with serum insulin ≥18 pmol/L), with available pre-operative Ga-DOTATATE PET/CT and CE-CT, and diagnosed with insulinoma confirmed by post-operative histopathology. Preoperative imaging was retrospectively analyzed by two radiologists who were blinded to the final diagnosis and to the results of other imaging modalities. Histopathology of specimen was considered the reference standard, and head-to-head comparison of preoperative CE-CT and PET imaging findings. Findings were classified as true positive (TP), true negative (TN), false positive (FP), and false negative (FN) for each modality. Based on these results, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of CE-CT, and Ga-DOTATATE PET/CT for the detection of insulinoma were calculated.

RESULTS

43 patients (N = 43 patients, L = 56 lesions), out of these, 37 patients had benign sporadic insulinoma (N = 37, L = 42), only 3 patients had malignant sporadic insulinoma (N = 2, L = 9), and 3 patients had MEN-1 syndrome associated insulinoma (N = 3, L = 5). There was no significant statistical difference in sensitivity (P = 0.3058) and PPV (P = 0.5533) for insulinoma localization in the overall cohort with Ga-DOTATATE PET/CT (87.5 %, 90.74 %) compared to CE-CT (80.36 %, 93.75 %).

CONCLUSION

Ga-DOTATATE PET/CT is a non-invasive imaging modality that can identify most insulinomas. Still, it offers limited additional information when the tumor is localized by other anatomic imaging studies, so should be used as an adjunct when imaging studies fail to localize the tumor in insulinoma patients, especially when minimally invasive surgical is intended.

摘要

目的

本回顾性研究旨在评估 Ga-DOTATATE PET/CT 在诊断和定位胰岛素瘤中的价值,包括散发性、恶性或 MEN-1 相关胰岛素瘤。

方法

该研究纳入了 43 例患者,这些患者存在临床(症状性低血糖)和/或实验室怀疑患有胰岛素瘤(72 小时禁食试验血清胰岛素≥18 pmol/L),且术前有 Ga-DOTATATE PET/CT 和 CE-CT 检查,并通过术后组织病理学诊断为胰岛素瘤。术前影像学由两位对最终诊断和其他影像学结果均不知情的放射科医生进行回顾性分析。组织病理学标本被视为参考标准,对术前 CE-CT 和 PET 成像结果进行头对头比较。对于每种方法,结果被分类为真阳性(TP)、真阴性(TN)、假阳性(FP)和假阴性(FN)。基于这些结果,计算了 CE-CT 和 Ga-DOTATATE PET/CT 对胰岛素瘤检测的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。

结果

43 例患者(N=43 例患者,L=56 个病灶)中,37 例为良性散发性胰岛素瘤(N=37 例,L=42 个病灶),仅 3 例为恶性散发性胰岛素瘤(N=2 例,L=9 个病灶),3 例为 MEN-1 综合征相关胰岛素瘤(N=3 例,L=5 个病灶)。在整个队列中,与 CE-CT(80.36%、93.75%)相比,Ga-DOTATATE PET/CT 对胰岛素瘤定位的敏感性(P=0.3058)和 PPV(P=0.5533)无显著统计学差异(87.5%、90.74%)。

结论

Ga-DOTATATE PET/CT 是一种非侵入性成像方式,可识别大多数胰岛素瘤。然而,当肿瘤通过其他解剖成像研究定位时,它提供的额外信息有限,因此当成像研究未能定位胰岛素瘤患者的肿瘤时,应将其作为辅助手段使用,特别是当计划进行微创外科手术时。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验